{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:31:31Z","timestamp":1762864291050,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":280,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1002\/rth2.12700","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T02:15:06Z","timestamp":1649988906000},"page":"e12700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Coagulation factor inhibitors in COVID\u201019: From SARS\u2010CoV\u20102 vaccination to infection"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-9685","authenticated-orcid":false,"given":"Jeremy W.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett S.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison P.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1002\/rth2.12700_bb0010","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s42399-020-00521-8","article-title":"Immune thrombocytopenia secondary to COVID\u201019: a systematic review","volume":"2","author":"Bhattacharjee","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"10.1002\/rth2.12700_bb0015","article-title":"COVID\u201019 and immune\u2010mediated RBC","author":"Jacobs","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/rth2.12700_bb0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41591-021-01419-1","article-title":"COVID\u201019 vaccination and immune thrombocytopenia","volume":"27","author":"Pishko","year":"2021","journal-title":"Nat Med"},{"key":"10.1002\/rth2.12700_bb0025","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/bjh.17024","article-title":"Clinical characteristics, management and outcome of COVID\u201019\u2010associated immune thrombocytopenia: a French multicentre series","volume":"190","author":"Mah\u00e9vas","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12700_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS\u2010CoV\u20102 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1002\/rth2.12700_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID\u201019 and coagulation: bleeding and thrombotic manifestations of SARS\u2010CoV\u20102 infection","volume":"136","author":"Al\u2010Samkari","year":"2020","journal-title":"Blood"},{"key":"10.1002\/rth2.12700_bb0040","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1002\/ajh.25865","article-title":"The first case of acquired hemophilia A associated with SARS\u2010CoV\u20102 infection","volume":"95","author":"Franchini","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1002\/rth2.12700_bb0045","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/trf.16254","article-title":"De novo acquired hemophilia as an immune dysregulation phenomenon following SARS\u2010CoV\u20102 infection","volume":"61","author":"Olsen","year":"2021","journal-title":"Transfusion"},{"key":"10.1002\/rth2.12700_bb0050","article-title":"A case of acquired hemophilia A following SARS\u2010CoV\u20102 infection","volume":"13","author":"Hafzah","year":"2021","journal-title":"Cureus"},{"key":"10.1002\/rth2.12700_bb0055","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jth.15291","article-title":"A case report of acquired hemophilia following COVID\u201019 vaccine","volume":"19","author":"Radwi","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1002\/rth2.12700_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.26426","article-title":"First and fatal case of autoimmune acquired factor XIII\/13 deficiency after COVID\u201019\/SARS\u2010CoV\u20102 vaccination","volume":"97","author":"Shimoyama","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1002\/rth2.12700_bb0065","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/hae.14442","article-title":"A case of acquired haemophilia A in a 70\u2010year\u2010old post COVID\u201019 vaccine","volume":"28","author":"Lemoine","year":"2022","journal-title":"Haemophilia"},{"issue":"12","key":"10.1002\/rth2.12700_bb0070","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1055\/a-1579-5396","article-title":"Autoimmunity after coronavirus disease 2019 (COVID\u201019)vaccine: a case of acquired hemophilia A","volume":"121","author":"Farley","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12700_bb0075","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1002\/rth2.12700_bb0080","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/bloodadvances.2021004957","article-title":"Autoimmune\u2010 and complement\u2010mediated hematologic condition recrudescence following SARS\u2010CoV\u20102 vaccination","volume":"5","author":"Portuguese","year":"2021","journal-title":"Blood Adv"},{"key":"10.1002\/rth2.12700_bb0085","doi-asserted-by":"crossref","first-page":"A1384","DOI":"10.1016\/j.chest.2021.07.1265","article-title":"\"Dark skin\"\u2010acquired hemophilia A after Pfizer\u2010BIONTECH COVID\u201019 vaccine","volume":"160","author":"Gonzalez","year":"2021","journal-title":"Chest"},{"key":"10.1002\/rth2.12700_bb0090","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.926728","article-title":"An 89\u2010year\u2010old man with COVID\u201019\u2010associated coagulopathy presenting with a prolonged partial thromboplastin time, lupus anticoagulant, and a high titer of factor VIII Inhibitor","volume":"21","author":"Ghafouri","year":"2020","journal-title":"Am J Case Rep"},{"key":"10.1002\/rth2.12700_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-242884","article-title":"Severe acquired haemophilia associated with asymptomatic SARS\u2010CoV\u20102 infection","volume":"14","author":"Wang","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1002\/rth2.12700_bb0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MBC.0000000000001009","article-title":"Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection","volume":"32","author":"Bennett","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"01","key":"10.1002\/rth2.12700_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0041-1735452","article-title":"Acquired factor V inhibitor after coronavirus disease 2019 (COVID\u201019)","volume":"48","author":"Chiurazzi","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12700_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.htct.2021.06.017","article-title":"Transient acquired factor XII deficiency associated with moderately severe Covid\u201019 pneumonia","volume":"43","author":"Murray","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1002\/rth2.12700_bb0115","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1055\/s-0040-1714696","article-title":"Acquired factor XI deficiency during SARS\u2010CoV\u20102 infection: not only thrombosis","volume":"4","author":"Andreani","year":"2020","journal-title":"TH Open"},{"key":"10.1002\/rth2.12700_bb0120","first-page":"498","article-title":"Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management","volume":"13","author":"Franchini","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1002\/rth2.12700_bb0125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12700_bb0130","article-title":"Acquired haemophilia A in association with influenza A and urinary tract infection","volume":"7","author":"Pe\u00f1a\u2010Mu\u00f1oz","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1002\/rth2.12700_bb0135","article-title":"An acquired factor VIII inhibitor in a patient with HIV and HCV: a case presentation and literature review","volume":"2013","author":"Zeichner","year":"2013","journal-title":"Case Rep Hematol"},{"key":"10.1002\/rth2.12700_bb0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00228-010-0852-z","article-title":"Acquired factor VIII haemophilia following influenza vaccination","volume":"66","author":"Moulis","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1002\/rth2.12700_bb0145","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2516.2011.02493.x","article-title":"A case of acquired haemophilia following H1N1 vaccination","volume":"17","author":"Pirrotta","year":"2011","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12700_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100761","article-title":"Coagulation and anticoagulation in COVID\u201019","volume":"47","author":"Hadid","year":"2021","journal-title":"Blood Rev"},{"key":"10.1002\/rth2.12700_bb0155","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID\u201019 and elevated D\u2010dimer concentration (ACTION): an open\u2010label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"issue":"10319","key":"10.1002\/rth2.12700_bb0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post\u2010discharge thromboprophylaxis after hospitalisation for COVID\u201019 (MICHELLE): an open\u2010label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti","year":"2022","journal-title":"Lancet"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12700","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12700","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:23:49Z","timestamp":1762863829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922011931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2475037922011931"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12700","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation factor inhibitors in COVID\u201019: From SARS\u2010CoV\u20102 vaccination to infection","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}],"article-number":"e12700"}}